MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients
Chi‐Tung Cheng(Chang Gung University), Chun‐Nan Yeh(Chang Gung University)
Cited by 7
Related Papers
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
|Oncotarget|2017|20
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
|Cancer Management and Research|2018|17